This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

DaVita, Fresenius move to dismiss US price-fixing claims over dialysis

( October 10, 2025, 22:31 GMT | Official Statement) -- MLex Summary: DaVita and Fresenius Medical Care told a US federal judge that plaintiffs have failed to allege a plausible agreement between them to fix prices in the dialysis industry. “[W]hile plaintiffs assert that defendants entered a price-fixing conspiracy, they cite no specific price charged by either defendant—ever. And despite claiming that FMC and DaVita avoid competing in undefined ‘areas,’ plaintiffs’ allegations make clear that DaVita and FMC compete extensively,” they said.See attached files. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections